References
- Grau LE, Dasgupta N, Harvey AP, Irwin K, Givens A, Kinzly ML, Heimer R. Illicit use of opioids: is OxyContin a "gateway drug"? Am J Addict. 2007;16:166–73. doi:https://doi.org/10.1080/10550490701375293.
- O’Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region—United States, 2006–2015. Morbidity and Mortality Weekly Report, Vol. 66. U.S. Department of Health and Human Services: Center for Disease Control and Prevention; 2017;66(34):897–903.
- Minhas M, Leri F. A multifaceted analysis of oxycodone addiction. Int J Ment Health Addiction. 2018;16(4):1016–32. doi:https://doi.org/10.1007/s11469-017-9827-y.
- Ren M, Lotfipour S. The role of the gut microbiome in opioid use. Behav Pharmacol. 2020;31:113–21. doi:https://doi.org/10.1097/FBP.0000000000000538.
- Meckel KR, Kiraly DD. A potential role for the gut microbiome in substance use disorders. Psychopharmacology (Berl). 2019;236:1513–30. doi:https://doi.org/10.1007/s00213-019-05232-0.
- Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108:16050–5. doi:https://doi.org/10.1073/pnas.1102999108.
- Xiao HW, Ge C, Feng GX, Li Y, Luo D, Dong JL, Li H, Wang H, Cui M, Fan SJ. Gut microbiota modulates alcohol withdrawal-induced anxiety in mice. Toxicol Lett. 2018;287:23–30. doi:https://doi.org/10.1016/j.toxlet.2018.01.021.
- Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatry. 2020;87:44–53. doi:https://doi.org/10.1016/j.biopsych.2019.05.023.
- Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65:1906–15. doi:https://doi.org/10.1136/gutjnl-2016-312297.
- Lee K, Vuong HE, Nusbaum DJ, Hsiao EY, Evans CJ, Taylor AMW. The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence. Neuropsychopharmacology. 2018;43:2606–14. doi:https://doi.org/10.1038/s41386-018-0211-9.
- Kiraly DD, Walker DM, Calipari ES, Labonte B, Issler O, Pena CJ, Ribeiro EA, Russo SJ, Nestler EJ. Alterations of the host microbiome affect behavioral responses to cocaine. Sci Rep. 2016;6:35455. doi:https://doi.org/10.1038/srep35455.
- Weiland A, Garcia S, Knackstedt LA. Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking. Front Pharmacol. 2015;6(44):1–11. doi:https://doi.org/10.3389/fphar.2015.00044.
- Alshehri FS, Hakami AY, Althobaiti YS, Sari Y. Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats. Behav Brain Res. 2018;347:368–76. doi:https://doi.org/10.1016/j.bbr.2018.03.043.
- Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes. 2018;9:252–7. doi:https://doi.org/10.4239/wjd.v9.i12.252.
- Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. Morb Mortal Wkly Rep. 2016;64:1378–82. doi:https://doi.org/10.15585/mmwr.mm6450a3.
- McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12–23. doi:https://doi.org/10.1016/j.cpr.2017.10.012.
- Agabio R, Campesi I, Pisanu C, Gessa GL, Franconi F. Sex differences in substance use disorders: focus on side effects. Addict Biol. 2016;21:1030–42. doi:https://doi.org/10.1111/adb.12395.
- Vasilenko SA, Evans-Polce RJ, Lanza ST. Age trends in rates of substance use disorders across ages 18–90: differences by gender and race/ethnicity. Drug Alcohol Depend. 2017;180:260–4. doi:https://doi.org/10.1016/j.drugalcdep.2017.08.027.
- Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280–e280. doi:https://doi.org/10.1371/journal.pbio.0060280.
- Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1:56–66. doi:https://doi.org/10.1038/ismej.2007.3.
- Knackstedt LA, Melendez RI, Kalivas PW. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry. 2010;67:81–4. doi:https://doi.org/10.1016/j.biopsych.2009.07.018.
- Sari Y, Sakai M, Weedman JM, Rebec GV, Bell RL. Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol. 2011;46:239–46. doi:https://doi.org/10.1093/alcalc/agr023.
- Hearing M, Graziane N, Dong Y, Thomas MJ. Opioid and psychostimulant plasticity: targeting overlap in nucleus accumbens glutamate signaling. Trends Pharmacol Sci. 2018;39:276–94. doi:https://doi.org/10.1016/j.tips.2017.12.004.
- Welling GW, Meijer-Severs GJ, Helmus G, van Santen E, Tonk RH, de Vries-Hospers HG, van der Waaij D. The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract. Infection. 1991;19:313–6. doi:https://doi.org/10.1007/BF01645354.
- Vincent C, Miller MA, Edens TJ, Mehrotra S, Dewar K, Manges AR. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection. Microbiome. 2016;4:12. doi:https://doi.org/10.1186/s40168-016-0156-3.
- Acharya C, Betrapally NS, Gillevet PM, Sterling RK, Akbarali H, White MB, Ganapathy D, Fagan A, Sikaroodi M, Bajaj JS. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(2):319–31. doi:https://doi.org/10.1111/apt.13858.
- Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352:565–9. doi:https://doi.org/10.1126/science.aad3369.
- Meng J, Yu H, Ma J, Wang J, Banerjee S, Charboneau R, Barke RA, Roy S. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS One. 2013;8:e54040. doi:https://doi.org/10.1371/journal.pone.0054040.
- Banerjee S, Sindberg G, Wang F, Meng J, Sharma U, Zhang L, Dauer P, Chen C, Dalluge J, Johnson T, et al. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol. 2016;9:1418–28. doi:https://doi.org/10.1038/mi.2016.9.
- Salarian A, Kadkhodaee M, Zahmatkesh M, Seifi B, Bakhshi E, Akhondzadeh S, Adeli S, Askari H, Arbabi M. Opioid use disorder induces oxidative stress and inflammation: the attenuating effect of methadone maintenance treatment. Iran J Psychiatry. 2018;13:46–54.
- Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh DC, et al. Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatr Dis Treat . 2014;10:2239–47.
- O’Sullivan SJ, Malahias E, Park J, Srivastava A, Reyes BAS, Gorky J, Vadigepalli R, Van Bockstaele EJ, Schwaber JS. Single-cell glia and neuron gene expression in the central amygdala in opioid withdrawal suggests inflammation with correlated gut dysbiosis. Front Neurosci. 2019;13(665):1–14. doi:https://doi.org/10.3389/fnins.2019.00665.
- Roberts RM, Bohm MK, Bartoces MG, Fleming-Dutra KE, Hicks LA, Chalmers NI. Antibiotic and opioid prescribing for dental-related conditions in emergency departments: United States, 2012 through 2014. J Am Dent Assoc. 2020;151:174–81.e1. doi:https://doi.org/10.1016/j.adaj.2019.11.013.
- Dana R, Azarpazhooh A, Laghapour N, Suda KJ, Okunseri C. Role of dentists in prescribing opioid analgesics and antibiotics: an overview. Dent Clin North Am. 2018;62:279–94. doi:https://doi.org/10.1016/j.cden.2017.11.007.